Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT06266494
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Frostbite
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Accepted
Interventions
- Long-Acting silver dressings — DEVICEMepilex Transfer Ag
- Aloe Vera — OTHERDermaid Aloe Vera
- Dalbavancin — DRUG1500mg IV dose
Study Details
This study will compare the effectiveness of two different treatments for preventing infection from frostbite injuries. These two treatments are A) aloe vera and B) long-acting silver wound dressings. The investigators will also study the safety and effectiveness of Dalbavancin, an FDA approved antibiotic used for treating people who develop frostbite wound infections, as well as evaluate how frostbite damage to individuals' bodies may affect how fast their kidney clear drugs from their systems.
Key Dates
- Start date
- Mar 1, 2024
- Status verified
- May 2024
- Primary completion
- May 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Aim 1: Aloe VeraAloe Vera will be applied topically to participant's frostbitten tissues twice daily.
- Experimental: Aim 1: Long-Acting Silver DressingsLong-Acting Silver dressings will be applied topically to participant's frostbitten tissues every 4 days.
- Experimental: Aim 2: DalbavancinParticipants will receive one 1500mg dose of Dalbavancin intravenously.
Primary Outcome Measure
The number of positive microbial wound cultures on admission [ Time Frame: Admission ]
Central Contacts
- Blaire Balstad303-724-7803
- Tracey MacDermott303-724-2757
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Denver Anschutz Medical Campus | Aurora | Colorado | 80045 |
Find similar trials in Aurora, CO
Related Studies
- Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)PHASE4 · Not Yet Recruiting · University of Colorado, Denver · Aurora, Colorado